From the Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612.
From the Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612.
J Biol Chem. 2013 Jul 19;288(29):20843-20855. doi: 10.1074/jbc.M112.443556. Epub 2013 Jun 6.
Although Parkinson disease (PD) is a progressive neurodegenerative disorder, available animal models do not exhibit irreversible neurodegeneration, and this is a major obstacle in finding out an effective drug against this disease. Here we delineate a new irreversible model to study PD pathogenesis. The model is based on simple castration of young male mice. Levels of inducible nitric-oxide synthase (iNOS), glial markers (glial fibrillary acidic protein and CD11b), and α-synuclein were higher in nigra of castrated male mice than normal male mice. On the other hand, after castration, the level of glial-derived neurotrophic factor (GDNF) markedly decreased in the nigra of male mice. Accordingly, castration also induced the loss of tyrosine hydroxylase-positive neurons in the nigra and decrease in tyrosine hydroxylase-positive fibers and neurotransmitters in the striatum. Reversal of nigrostriatal pathologies in castrated male mice by subcutaneous implantation of 5α-dihydrotestosterone pellets validates an important role of male sex hormone in castration-induced nigrostriatal pathology. Interestingly, castration was unable to cause glial activation, decrease nigral GDNF, augment the death of nigral dopaminergic neurons, induce the loss of striatal fibers, and impair neurotransmitters in iNOS(-/-) male mice. Furthermore, we demonstrate that iNOS-derived NO is responsible for decreased expression of GDNF in activated astrocytes. Together, our results suggest that castration induces nigrostriatal pathologies via iNOS-mediated decrease in GDNF. These results are important because castrated young male mice may be used as a simple, toxin-free, and nontransgenic animal model to study PD-related nigrostriatal pathologies, paving the way for easy drug screening against PD.
虽然帕金森病(PD)是一种进行性神经退行性疾病,但现有的动物模型并不表现出不可逆转的神经退行性变,这是寻找有效治疗这种疾病的药物的主要障碍。在这里,我们描述了一种新的不可逆模型来研究 PD 的发病机制。该模型基于对年轻雄性小鼠进行简单的去势。去势雄性小鼠的黑质中诱导型一氧化氮合酶(iNOS)、神经胶质标志物(胶质纤维酸性蛋白和 CD11b)和α-突触核蛋白的水平高于正常雄性小鼠。另一方面,去势后,雄性小鼠黑质中的胶质源性神经营养因子(GDNF)水平明显下降。因此,去势也诱导了黑质中酪氨酸羟化酶阳性神经元的丧失以及纹状体中酪氨酸羟化酶阳性纤维和神经递质的减少。通过皮下植入 5α-二氢睾酮丸来逆转去势雄性小鼠的黑质纹状体病理学,验证了雄性性激素在去势诱导的黑质纹状体病理学中的重要作用。有趣的是,去势不能引起神经胶质细胞的激活,减少黑质 GDNF,增加黑质多巴胺能神经元的死亡,诱导纹状体纤维的丧失,并损害 iNOS(-/-)雄性小鼠纹状体中的神经递质。此外,我们证明 iNOS 衍生的 NO 负责激活的星形胶质细胞中 GDNF 表达的降低。总之,我们的结果表明,去势通过 iNOS 介导的 GDNF 减少诱导黑质纹状体病理学。这些结果很重要,因为去势的年轻雄性小鼠可能被用作一种简单、无毒素和非转基因的动物模型来研究与 PD 相关的黑质纹状体病理学,为针对 PD 的药物筛选铺平了道路。